Build Nanobody-Drug Conjugates

This workflow is built on camelid antibody biology. It uses the structure and properties of camelid antibodies to create small, stable nanobodies that can bind tightly to a chosen target.

Outcome

A designed nanobody-drug conjugate ready for therapeutic testing.